核心观点：25Q1-3 整体行业业绩同比下滑；25Q3 环比改善，海外&创新类资产韧性十足。根据wind，25Q1-3，A 股医疗器械板块（剔除受新冠影响企业）整体收入同比下滑1.1%；整体归母净利润同比下滑15%；整体归母净利润率为15.70%，较24Q1-3 同比下降2.50pct。根据wind，25Q3，A 股医疗器械板块（剔除受新冠影响企业）整体收入同比提升4.4%，环比25Q2 下滑...
Source Link核心观点：25Q1-3 整体行业业绩同比下滑；25Q3 环比改善，海外&创新类资产韧性十足。根据wind，25Q1-3，A 股医疗器械板块（剔除受新冠影响企业）整体收入同比下滑1.1%；整体归母净利润同比下滑15%；整体归母净利润率为15.70%，较24Q1-3 同比下降2.50pct。根据wind，25Q3，A 股医疗器械板块（剔除受新冠影响企业）整体收入同比提升4.4%，环比25Q2 下滑...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.